31 YEARS
Since 1994
Leadership

Founder

The vision and leadership that built Vasudha Pharma Chem Limited into a trusted global API manufacturer.

Our Company

About Us

Building trust through quality science since 1994 — the story of Vasudha Pharma Chem Limited.

From the Leadership

Director’s Message

For three decades, Vasudha Pharma Chem has held a single conviction: contributing to healthcare is to take responsibility for life – beyond our factory gates.

Sustainability, here is a discipline rather than a department. We invest in cleaner chemistries and zero-liquid-discharge systems that exceed every standard we operate under.

Our commitment to community is older than the law. Through the Vasudha Foundation, we bring clear water to schools, education to children in tribal regions, and care to patients without means – consistently giving beyond what CSR requires.

Medicine, at its finest, is compassion practiced at scale.

— Sri M V Rama Raju
Chairman & Managing Director

From the Leadership

Chairman’s Address

Since our founding in 1994, Vasudha Pharma Chem Limited has been guided by a clear purpose: to contribute to affordable healthcare through high-quality Active Pharmaceutical Ingredients and intermediates.

Our journey from a focused intermediates manufacturer to a diversified API company with multiple USFDA and WHO-GMP approved sites reflects the dedication of our teams, the trust of our customers and our continuous investment in technology, quality systems and people.

We remain committed to sustainable and quality growth — offering products that meet the expectations of regulators and global pharmaceutical companies, while upholding the highest standards of ethics, environment and social responsibility.

— Sri M V Rama Raju
Chairman & Managing Director

Vasudha Pharma Chem Limited (CIN: U24230TG1994PLC019021) was incorporated in 1994 at Hyderabad, Telangana, India. We are engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and Pharma Intermediates for domestic as well as international markets.

From our early focus on cost-effective processes for piperidone & piperidine derivatives, we have grown into a trusted global supplier with multiple manufacturing units and strong regulatory credentials.

Our Vision — To achieve sustainable & quality growth. Offering quality products to the globe that satisfy the requirements of regulators and global pharma companies.

USFDA
WHO-GMP
KFDA / MFDS
COFEPRIS
ISO 14001
OHSAS 18001
EcoVadis
EDQM
PMDA
ANVISA
CDSCO
FDA
USFDA
WHO-GMP
KFDA / MFDS
COFEPRIS
ISO 14001
OHSAS 18001
EcoVadis
EDQM
PMDA
ANVISA
CDSCO
FDA
About Us

Company Profile

Vasudha Pharma Chem Limited (CIN: U24230TG1994PLC019021) was incorporated in 1994–95 as a public limited company under the Companies Act, 1956 at Hyderabad, Telangana, India. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and Pharma Intermediates for domestic as well as international markets.

Initially the focus was on cost-effective processes for intermediates related to piperidone & piperidine derivatives. By 2003–04 the company gained world-class expertise and became a leading manufacturer of these derivatives. Subsequently it forward-integrated into APIs and diversified into a portfolio of 40+ APIs across several therapeutic areas.

A dedicated R&D facility with 100+ scientists was set up in 2017. The company operates multiple manufacturing units with strong regulatory credentials including USFDA, WHO-GMP, KFDA and Mexican MOH approvals.

Leadership

Board of Directors

Our board brings deep technical and commercial experience in the pharmaceutical industry, guiding strategy, quality and sustainable growth.

Sri M V Rama Raju - CMD, VPCL

Sri M V Rama Raju

CMD, VPCL

A postgraduate in Organic Chemistry with around 41 years of experience in the manufacture of Active Pharmaceutical Ingredients. He began his career at the South India Research Institute (1972–76), founded Arvind Chemicals in 1976 and Hyfabs in 1979, and was founder–Managing Director of Hicel Pharma (P) Ltd from 1984–89. He established Vasudha Pharma Chem Limited in 1994–95 and has led it since inception, driving production, product development, marketing strategy, capacity expansion and cGMP upgradation.

Ashok Srinivas Raju Mantena - Executive Director

Ashok Srinivas Raju Mantena

Executive Director

B.E. Chemical Engineering from M S Ramaiah Institute of Technology, Bangalore (1995) and M.S. Chemical Engineering from the University of Toledo, Ohio (1997). A full-time Director since 1998 with 27 years in bulk drug manufacturing, he looks after manufacturing activities, HR & Industrial Relations, administration and collaborations, and is closely involved in major project implementation across the group.

Anand Mantena - Executive Director

Sri M Anand

Executive Director

An MBA in Finance and a full-time Director since 1998, with 27 years of experience in bulk drug manufacturing. He oversees raw material purchases, information technology services, legal, liaison and commercial activities, and contributes actively to marketing inputs.

Operations

Management Team

Senior leaders across marketing, finance, operations, quality and corporate functions who run the business day to day.

Our Journey

30+ Years of Quality, Scale & Global Trust

From our inception in 1994 with Unit-I to an 8-facility API powerhouse with 2,000+ KL synthesis capacity, USFDA approvals, and exports to 90+ countries worldwide.

1994
Year of Incorporation
30+ Years of Manufacturing Heritage
8 Units
Manufacturing Facilities
USFDA & WHO-GMP Compliant Clusters
2,000+ KL
Total Reactor Capacity
Advanced Synthesis & Automation
90+ Countries
Global Market Presence
US, Europe, Japan, Latin America & Asia
1994 Corporate Inception

Incorporation in Hyderabad

Vasudha Pharma Chem Limited was incorporated at Hyderabad, Telangana, establishing the corporate mission to manufacture world-class Active Pharmaceutical Ingredients (APIs) and advanced intermediates.

Founding Milestone • Hyderabad, India
1997 – 1998 Facility Expansion

Unit-I Commercial Commencement

Commercial synthesis began at Unit-I in Jeedimetla, Hyderabad, with multi-stage reaction trains, establishing Vasudha's initial market presence and turnover.

Unit-I Operational • Initial Commercial Scale
2002 Facility Acquisition

Acquisition of Unit-VI Intermediate Hub

Acquired and integrated Unit-VI across 5.17 acres, purpose-engineered with heavy-duty glass-lined reactor capacity for specialized chlorination and key starting material (KSM) integration.

Unit-VI Integration • Speciality Intermediates
2003 – 2004 Accreditation & Awards

WHO-GMP Certification & CHEMEXCIL Honors

Obtained WHO-GMP certification for leading APIs manufactured at Unit-I. Conferred the CHEMEXCIL First Award for Outstanding Export Performance by the Ministry of Commerce.

WHO-GMP Conferred • CHEMEXCIL First Award
2005 – 2006 Business Scale

INR 1.00 Billion Turnover & Star Export House

Annual group turnover crossed the INR 1.00 Billion milestone. Conferred official Star Export House status in recognition of rapid international market expansion.

INR 1.00 Billion Gross Revenue • Star Export House
2008 – 2009 Capacity Leap

Unit-II Commissioning & INR 2.00 Billion Turnover

Commissioned the large-scale Unit-II campus across 10.63 acres. Secured WHO-GMP certification for Unit-II as annual turnover doubled past INR 2.00 Billion.

Unit-II Online • Commercial API Synthesis
2010 Global Regulatory

USFDA Approval & Zero 483 Observations

Passed comprehensive USFDA inspection for Unit-I with zero 483 observations, marking entry into prime North American pharmaceutical supply chains. Concurrently secured Mexican MOH (COFEPRIS) and South Korean KFDA clearances.

USFDA Approved (Zero 483) • COFEPRIS & KFDA
2011 – 2012 PMDA Japan & Scale

PMDA Japan Accreditation & INR 4.00 Billion Milestone

Conferred PMDA Japan GMP certification and Foreign Manufacturer accreditation for high-purity API supply. Turnover surged past INR 4.00 Billion with established customer relationships across 45+ countries.

PMDA Japan Accredited • INR 4.00 Billion Revenue
2012 – 2014 Coastal Hub

Unit-III Commercial Launch & European CEP Approvals

Commenced commercial operations at Unit-III in JN Pharma City, Visakhapatnam (9.02 acres). Secured European Written Confirmation (EU-WC) and granted EDQM Certificates of Suitability (CEP) for European markets.

Unit-III Online • EDQM CEP & EU-WC Confirmed
2016 – 2017 R&D & Formulations

Vikasith R&D Center & Unit-IV Pellet Facility

Inaugurated the dedicated Vikasith R&D Center housing 100+ research scientists, kilo-labs, and modern analytical instrumentation. Concurrently commissioned Unit-IV for specialty pellets and sustained-release formulations.

100+ R&D Scientists • Unit-IV Pellets Operational
2019 Mega Synthesis Site

Unit-V Advanced Manufacturing Campus

Commissioned the sprawling Unit-V manufacturing complex at Atchutapuram across 26.02 acres, featuring multi-purpose synthesis blocks and modern cGMP finishing suites.

Unit-V Flagship Facility • APSEZ Atchutapuram • 26 Acres
2021 – 2022 Infrastructure Milestone

Advanced Synthesis & Formulation Infrastructure

Expanded group-wide chemical synthesis and advanced formulation capabilities across cGMP production units. Installed high-capacity automated coating trains in Unit-IV and achieved EDQM CEP approval for Olmesartan Medoxomil.

Multi-Unit Scale • Advanced Coating Lines
2023 – 2024 Sustainability & ESG

EcoVadis Silver Medal & Green Energy Leadership

Conferred the globally recognized EcoVadis Silver Medal for ESG excellence. Installed 4.8+ MWp captive rooftop solar generation, commissioned 1,200+ KLD Zero Liquid Discharge (ZLD) systems, and renewed ISO 14001 & ISO 45001 across all facilities.

EcoVadis Silver Medal • 4.8 MWp Solar • 1,200 KLD ZLD
2025 – 2026 Global CDMO Partner

90+ Global Markets & Advanced CDMO Pipeline

Supplying 265+ commercial APIs, Pellets and Intermediates to top-tier global pharmaceutical companies across 90+ countries. Advanced flow chemistry, complex chemical synthesis, and custom CDMO routes serving global healthcare access.

265+ Commercial Molecules • 90+ Countries • Custom CDMO
Global Reach

International Market Presence

Vasudha Pharma Chem Limited supplies APIs and intermediates to customers worldwide. Export sales form a significant share of our business, supported by strong regulatory approvals and a reputation for quality, timely delivery and competitive pricing.

Our manufacturing sites hold approvals and certifications including USFDA, WHO-GMP, KFDA, Mexican MOH (COFEPRIS), and other international authorities, enabling access to regulated markets across continents.

United States flag United States USFDA approved sites
Europe flag Europe EDQM / CEP & EU access
Mexico flag Latin America Mexican MOH certified
Korea flag Asia KFDA & regional markets
Japan flag Japan PMDA related supply
Global markets Global MNCs Prime source for key products
United States flag United States USFDA approved sites
Europe flag Europe EDQM / CEP & EU access
Mexico flag Latin America Mexican MOH certified
Korea flag Asia KFDA & regional markets
Japan flag Japan PMDA related supply
Global markets Global MNCs Prime source for key products

Partner with a trusted API manufacturer

Whether you need high-quality APIs, intermediates or custom manufacturing support, our team is ready to collaborate.

Contact Our Team